Prospects for better tuberculosis vaccines
- 1 August 2001
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 1 (1) , 21-28
- https://doi.org/10.1016/s1473-3099(01)00018-4
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB 421)
- Bundesministerium für Bildung und Forschung
- Verband der Chemischen Industrie
This publication has 36 references indexed in Scilit:
- Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette–Guérin (BCG) vaccinationClinical and Experimental Immunology, 2001
- The Toll receptor family and microbial recognitionTrends in Microbiology, 2000
- Is the development of a new tuberculosis vaccine possible?Nature Medicine, 2000
- Exploiting the immune system: Toward new vaccines against intracellular bacteriaPublished by Elsevier ,2000
- Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative TreatmentNew England Journal of Medicine, 1999
- The effect of heterologous immunity upon the apparent efficacy of (e.g. BCG) vaccinesVaccine, 1998
- Modeling the impact of global tuberculosis control strategiesProceedings of the National Academy of Sciences, 1998
- An Antimicrobial Activity of Cytolytic T Cells Mediated by GranulysinScience, 1998
- gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?Proceedings of the National Academy of Sciences, 1996
- Efficacy of BCG Vaccine in the Prevention of TuberculosisJAMA, 1994